Katkin Keith 4
4 · Eledon Pharmaceuticals, Inc. · Filed Jan 16, 2026
Insider Transaction Report
Form 4
Katkin Keith
Director
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-01-10+8,575→ 8,575 total - Exercise/Conversion
Restricted Stock Units
[F1]2026-01-10−8,575→ 0 total→ Common Stock (8,575 underlying)
Footnotes (1)
- [F1]Represents shares issuable on settlement of restricted stock units ("RSUs") for common stock on a one-for-one basis granted to the reporting person. The RSUs were issued on January 10, 2025 and vested 100% on January 10, 2026.
Signature
/s/ Paul Little, as attorney-in-fact for Keith Katkin|2026-01-16